Answers are grounded in this paper and cite their sources.
The selection of effective antiepileptic therapy is an important task for any neurologist. Despite many studies in the field of epileptology, about 30 % of all patients do not achieve stable pharmacological remission. A promising direction in the treatment of epilepsy is the use of drugs from the group of antioxidants. One of the new drugs of this type, which have shown their effectiveness, is Dibufelon, a drug of phenosanic acid. This literature review highlights the main etiological, pathogenetic and pharmacological aspects of the use of a new drug.
No takes yet. Share an insight, caveat, or question.
Салтанова et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: